Skip to main content

Table 2 cTnI Values and the AICS Clinical Decision: Arm-2

From: Beckman Access versus the Bayer ACS:180 and the Abbott AxSYM cardiac Troponin-I real-time immunoassays: an observational prospective study

BA cTnI Value1

AX cTnI Value2

AICS Present # of Samples

AICS Not Present # of Samples

Negative

Negative

0

4

Negative

Indeterminate

0

1

Negative

Positive

0

0

Indeterminate

Negative

6

22

Indeterminate

Indeterminate

0

4

Indeterminate

Positive

2

1

Positive

Negative

2

10

Positive

Indeterminate

0

2

Positive

Positive

38

2

  1. 1 BA Assay: negative <0.03 ng/ml, indeterminate = 0.03–0.15 ng/ml, positive >0.15 ng/ml 2 AX Assay: negative <0.40 ng/ml, indeterminate = 0.40–1.90 ng/ml, positive >1.90 ng/ml